Ozone therapy: Clinical and basic evidence of its therapeutic potential

被引:119
作者
Re, Lamberto [1 ]
Mawsouf, Mohamed N. [2 ]
Menendez, Silvia [3 ]
Leon, Olga S. [4 ]
Sanchez, Gregorio M. [4 ]
Hernandez, Frank [3 ]
机构
[1] Univ Ancona, I-60100 Ancona, Italy
[2] Cairo Univ, Natl Canc Inst, Ozone Therapy Unit, Cairo, Egypt
[3] Ozone Res Ctr, Havana, Cuba
[4] Univ Havana, Ctr Studies Res & Biol Evaluat, IFAL, Havana, Cuba
关键词
ozone; ozone preconditioning; diabetes; Parkinson's disease; rotenone; ischemia/reperfusion;
D O I
10.1016/j.arcmed.2007.07.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ozone has recently been subjected to criticism and emphasis in relation to clinical efficacy and toxicity, respectively. Without a doubt, ozone, in common with oxygen itself, is one of the most potent oxidants. Ozone is considered one of the major pollutants in urban areas. Nevertheless, increasingly widespread use lately has highlighted the potential benefits as a therapeutic agent when used according to well-defined and safe protocols. Basic studies conducted following rigorous scientific and ethical criteria have been proposed for scientific discussion. This paper concerns original data on an in vivo model of Parkinson's disease and published data on the effect of low ozone doses with any risk of toxicity excluded with the concentrations commonly used in medical applications. (C) 2008 IMSS. Published by Elsevier Inc.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 50 条
[41]   Basic science in Parkinson’s disease: its impact on clinical practice [J].
Jörg B. Schulz ;
Manfred Gerlach ;
Gabriele Gille ;
Wilfried Kuhn ;
Martina Müngersdorf ;
Peter Riederer ;
Martin Südmeyer ;
Albert Ludolph .
Journal of Neurology, 2011, 258 :299-306
[42]   Basic science in Parkinson's disease: its impact on clinical practice [J].
Schulz, Joerg B. ;
Gerlach, Manfred ;
Gille, Gabriele ;
Kuhn, Wilfried ;
Muengersdorf, Martina ;
Riederer, Peter ;
Suedmeyer, Martin ;
Ludolph, Albert .
JOURNAL OF NEUROLOGY, 2011, 258 :S299-S306
[43]   Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence [J].
Kawanami, Daiji ;
Matoba, Keiichiro ;
Sango, Kazunori ;
Utsunomiya, Kazunori .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08)
[44]   The clinical heterogeneity of Parkinson's disease and its therapeutic implications [J].
Greenland, Julia C. ;
Williams-Gray, Caroline H. ;
Barker, Roger A. .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) :328-338
[45]   Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies [J].
Zeng, Yujiao ;
Luo, Yuting ;
Wang, Lijie ;
Zhang, Kun ;
Peng, Jiayan ;
Fan, Gang .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
[46]   Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions [J].
Zhu, Xiaolin ;
Zhang, Yu ;
Yang, Xin ;
Hao, Chunyan ;
Duan, Hubin .
FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
[47]   Effect of α-tocopherol during in vitro ozonation of methyl linoleate:: its implication in ozone therapy [J].
Gómez, MFD ;
Sazatornil, JAG ;
Rosales, FH ;
Rubí, WD .
OZONE-SCIENCE & ENGINEERING, 2004, 26 (02) :189-194
[48]   Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders [J].
White, Caitlin M. ;
Ji, Sunggoan ;
Cai, Huan ;
Maudsley, Stuart ;
Martin, Bronwen .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (05) :661-666
[49]   Ferroptosis in immune chaos: Unraveling its impact on disease and therapeutic potential [J].
Direksunthorn, Thanyaporn ;
T. Ahmed, Abdulrahman ;
Pluetrattanabha, Nakaraj ;
Uthirapathy, Subasini ;
Ballal, Suhas ;
Singh, Abhayveer ;
Al-Hetty, Hussein Riyadh Abdul Kareem ;
Devi, Anita ;
Sharma, Girish Chandra ;
Yumashev, Alexey .
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2025, 81 (02) :249-272
[50]   α-Synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy [J].
Paleologou, KE ;
Irvine, GB ;
El-Agnaf, OMA .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 :1106-1110